As of Dec 11
| -0.0098 / -2.58%|
The 1 analysts offering 12-month price forecasts for Tenax Therapeutics Inc have a median target of 2.50, with a high estimate of 2.50 and a low estimate of 2.50. The median estimate represents a +575.31% increase from the last price of 0.37.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.